Organization & Developments: Bluejay Diagnostics

Parents

2021: Bluejay Diagnostics: Providing Rapid Lab Quality Results In Near-Patient-Care Settings
Bluejay Diagnostics, Inc. (BJDX) is a “late-stage pre-revenue” medical diagnostic solutions company developing innovative and minimally invasive products that provide laboratory quality results in “near-patient-care” situations.
Bluejay Diagnostics, Inc. is developing easy-to-use, point-of-care medical diagnostics tests.
Bluejay’s tests are affordable and time-sensitive, enabling life-saving decision-making for treatments with a rapid sample-to-result time frame of less than 25 minutes.
The Company’s lead product is the Symphony platform, an exclusively licensed, patented, low-cost, table-top system that uses indication-specific, single-use test cartridges.
The Symphony platform technology was developed over 12 years by Toray Industries, Inc. Bluejay licenses the technology from Toray, who are also invested as shareholders in the Company since 2020.